Therapeutic Potential of PPARγ Activation in Stroke

被引:11
|
作者
Vemuganti, Raghu [1 ,2 ]
机构
[1] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA
[2] Univ Wisconsin, Neurosci Training Program, Madison, WI 53792 USA
关键词
D O I
10.1155/2008/461981
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptional regulation of genes that promote these pathophysiological mechanisms can be an effective strategy to minimize the poststroke neuronal death. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors known to be upstream to many inflammatory and antioxidant genes. The goal of this review is to discuss the therapeutic potential and putative mechanisms of neuroprotection following PPAR activation after stroke. Copyright (C) 2008 Raghu Vemuganti
引用
收藏
页数:9
相关论文
共 50 条
  • [1] PPAR-γ:: therapeutic target for ischemic stroke
    Culman, Juraj
    Zhao, Yi
    Gohlke, Peter
    Herdegen, Thomas
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (05) : 244 - 249
  • [2] PPARα: A potential therapeutic target of cholestasis
    Ye, Xiaoyin
    Zhang, Tong
    Han, Han
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Combined PPARγ Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors
    Leung, Dilys T. H.
    Nguyen, Trang
    Oliver, Edwina May
    Matti, Juliana
    Alexiadis, Maria
    Silke, John
    Jobling, Thomas W.
    Fuller, Peter J.
    Chu, Simon
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (02) : 364 - 375
  • [4] PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective
    Morales, M. Lizeth Orozco
    Rinaldi, Catherine A.
    de Jong, Emma
    Lansley, Sally M.
    Gummer, Joel P. A.
    Olasz, Bence
    Nambiar, Shabarinath
    Hope, Danika E.
    Casey, Thomas H.
    Lee, Y. C. Gary
    Leslie, Connull
    Nealon, Gareth
    Shackleford, David M.
    Powell, Andrew K.
    Grimaldi, Marina
    Balaguer, Patrick
    Zemek, Rachael M.
    Bosco, Anthony
    Piggott, Matthew J.
    Vrielink, Alice
    Lake, Richard A.
    Lesterhuis, W. Joost
    ISCIENCE, 2022, 25 (01)
  • [5] Potential Therapeutic Effects of PPAR Ligands in Glioblastoma
    Basilotta, Rossella
    Lanza, Marika
    Casili, Giovanna
    Chisari, Giulia
    Munao, Stefania
    Colarossi, Lorenzo
    Cucinotta, Laura
    Campolo, Michela
    Esposito, Emanuela
    Paterniti, Irene
    CELLS, 2022, 11 (04)
  • [6] PPAR-γ: Therapeutic Potential for Multiple Sclerosis
    Drew, Paul D.
    Xu, Jihong
    Racke, Michael K.
    PPAR RESEARCH, 2008, 2008
  • [7] Therapeutic roles of PPARα activation in ocular ischemic diseases
    Lee, Deokho
    Tomita, Yohei
    Negishi, Kazuno
    Kurihara, Toshihide
    HISTOLOGY AND HISTOPATHOLOGY, 2023, 38 (04) : 391 - 400
  • [8] PPARγ Activation: A Potential Treatment for Pulmonary Hypertension
    Hansmann, Georg
    Zamanian, Roham T.
    SCIENCE TRANSLATIONAL MEDICINE, 2009, 1 (12)
  • [9] Microglial Activation in Stroke: Therapeutic Targets
    Yenari, Midori A.
    Kauppinen, Tiina M.
    Swanson, Raymond A.
    NEUROTHERAPEUTICS, 2010, 7 (04) : 378 - 391
  • [10] Microglial activation in stroke: Therapeutic targets
    Midori A. Yenari
    Tiina M. Kauppinen
    Raymond A. Swanson
    Neurotherapeutics, 2010, 7 : 378 - 391